FDA
-
-
-
-
-
-
-
enVVeno Medical receives first U.S. patent for venous valve system
-
-
-
-
-
-
-
enVVeno Medical Receives First-Ever FDA IDE Approval for a U.S. Pivotal Study of a Non-Surgical Replacement Venous Valve
-
-
-
-
-
-
-
enVVeno Medical Updates Regulatory Status of VenoValve(R)
-
-
-
-
-
-
-
Positive Interim 2-Year Data from enVVeno Medical's VenoValve Pivotal Study to be Presented Today at the Society for Vascular Surgery (SVS) 2025 Vascular Annual Meeting
-
-
-
-
-
-
-
enVVeno Medical Reports Fourth Quarter and Year-End 2024 Financial Results and Progress Towards VenoValve FDA Approval Expected in 2H25
-
-
-
-
-
-
-
enVVeno Medical to Present Definitive One Year Data from the VenoValve U.S. Pivotal Trial Today at the 51st Annual VEITH Symposium
-
-
-
-
-
-
-
enVVeno Medical (NVNO) Provides Update on FDA Premarket Approval Application Status for VenoValve
-
334,437 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


